Reference is made to the key information notice on 25 February 2026 published
by Aqua Bio Technology ASA (the "Company"). The shares of the Company are
trading exclusive the share consolidation (reverse share split) as of today,
as described below.
Issuer name: Aqua Bio Technology ASA
Ex-date: 27 February 2026
Type of corporate action: Share consolidation (reverse share split)
Reverse split ratio: 50:1, i.e. fifty (50) old shares give one (1) new share.
Other information: Following completion of the share consolidation, the new
number of issued shares of the Company will be 3,227,935 shares, each with a
par value of NOK 5.00.
New ISIN: NO 001 3735894
Contacts
Kristian Flaten
CEO & CFO
Aqua Bio Technology ASA
Phone: +47 9509 2322
Email: kf@aquabiotech.no
About Us
Aqua Bio Technology ASA (ABTEC) is a technology and distribution group in
skincare and nonfood. The group has distribution towards B2C and B2B, and
offers freight, customs, and logistics services. The group also develops
sustainable biotechnology for use in skincare products. Aqua Bio Technology is
listed on Euronext Expand Oslo.
This notice is published by Kristian Flaten on the listed date and time.
This information has been submitted pursuant to the Securities Trading Act §
5-12 and MAR Article 17. The information was submitted for publication,
through the agency of the contact persons set out above, at 2026-02-27 07:40
CET.